Karma Ventures invest into early-stage deep tech software in Baltics, Nordics, and in especially strong cases also elsewhere in Europe.
They’re looking for companies with technological advantage. Doesn’t have to be IPR, but something valuable and very hard to imitate. They look for companies with traction, first clients validating the demand, but in exceptional cases pre-revenue can also be considered.
In terms of sectors, life sciences are not their focus, but deep tech B2B health software can be interesting.
They prefer to lead, co-lead or invest solo.
Ticket size: €500k-€3,000k, maximum allocation with follow-on investments €10,000k per company